Eradication Rates of Helicobacter Pylori and Its Affecting Factors

• Status: Completed
• Trial end date: 2013-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the trend of eradication rates of first-line triple therapy for Helicobacter pylori in recent ten years and clinical factors that affect the eradication in Korean.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital

Criteria

Inclusion Criteria:

• Patients who proven H. pylori infection by invasive or non-invasive H. pylori test

• Patients treated with First-line triple therapy (PPI + Amoxicillin + Clarithromycin)

Exclusion Criteria:

• Previous eradication therapy for H. pylori

• Follow-up loss patients after eradication therapy

• Other treatment regimen

• Poor medication compliance (<80%)